MAGE-A10 796T TCR therapy

MAGE-A10 targeted T-cell receptor therapy · Adaptimmune

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAGE-A10 796T TCR therapy, covering 2025-12-09 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC [Phase 1]